Xenetic Biosciences Inc. (XBIO)

AI Score

Unlock

2.72

0.17 (6.67%)

At close: Apr 24, 2025, 3:56 PM

2.83

4.08%

After-hours: Apr 24, 2025, 07:38 PM EDT

Dividends

No dividend history available for Xenetic Biosciences Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield

Dividend Rankings

XBIO News

2 weeks ago · Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment - accessnewswire.com
4 weeks ago · Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma - accessnewswire.com
1 month ago · Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results - accessnewswire.com
1 month ago · Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses - accessnewswire.com
1 month ago · Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting - accessnewswire.com